PlainRecalls
FDA Devices Critical Class I Terminated

LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098

Reported: July 7, 2021 Initiated: May 7, 2021 #Z-1954-2021

Product Description

LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098

Reason for Recall

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.

Details

Units Affected
441 kits (192 tests/kit = 84,672 tests)
Distribution
Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.
Location
North Billerica, MA

Frequently Asked Questions

What product was recalled?
LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098. Recalled by Magellan Diagnostics, Inc.. Units affected: 441 kits (192 tests/kit = 84,672 tests).
Why was this product recalled?
Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 7, 2021. Severity: Critical. Recall number: Z-1954-2021.